Business Wire - Coulter Pharmaceutical And SmithKline Beecham Combine Bexxar With CVP Chemotherapy in a New First-Line Clinical Trial
Sunday, November 30th, 2008 Business Editors & Health/Medical Writers
SOUTH SAN FRANCISCO, Calif./PHILADELPHIA–(BW HealthWire)–April 26, 2000
Coulter Pharmaceutical (Nasdaq:CLTR) and SmithKline Beecham (NYSE:SBH) today announced a Phase II multicenter investigational trial of Bexxar(TM) …
